TB-500 5MG + BPC-157 5MG

"Wolverine Stack" Regenerative Peptide Blend for Research Use

Category: Tissue Repair & Regeneration Peptide Blends

TB500-BPC157-10MG | Form: Lyophilized Powder | Purity: ≥ 99% (HPLC Tested)

Product Overview

The TB-500 and BPC-157 blend combines two of the most researched regenerative peptides in preclinical science, creating a synergistic formulation for advanced studies on wound healing, tissue repair, inflammation modulation, and angiogenesis. TB-500, a synthetic fragment of Thymosin Beta-4, enhances cellular migration and blood vessel growth, while BPC-157, derived from a natural body protection compound, accelerates tissue recovery and reduces oxidative damage. Together, this 10mg/10mg formulation serves as a robust model compound for investigating cellular regeneration, collagen synthesis, and recovery from muscular or connective tissue injury.

Enhances actin polymerization, angiogenesis, fibroblast migration, and anti-inflammatory responses

Research Summary

TB-500 and BPC-157 have been extensively studied in preclinical settings for their complementary roles in regeneration and healing. TB-500 primarily enhances actin cytoskeleton organization and angiogenesis, promoting new blood vessel formation and tissue remodeling. BPC-157 accelerates fibroblast proliferation, collagen synthesis, and inflammatory modulation. When combined, these peptides demonstrate additive or synergistic effects in cellular regeneration and recovery.

Key research findings include:

• Accelerated wound closure and collagen remodeling in dermal and tendon injury models (FASEB J, 2004; Exp Cell Res, 2015).
• Enhanced angiogenesis and endothelial stability through VEGF and integrin activation (Circulation, 2017).
• Reduced oxidative stress and inflammatory cytokine activity (MDPI Pharmaceuticals, 2023).
• Improved muscle regeneration and decreased fibrosis in preclinical tissue repair studies (Nature, 2012).

This TB-500 and BPC-157 blend provides researchers with a combined platform for exploring multi-pathway regenerative processes and anti-inflammatory mechanisms in vitro and in vivo.

Applications in Research

• Tendon, ligament, and muscle injury repair models
• Wound healing and skin regeneration studies
• Angiogenesis and vascular support research
• Fibrosis and scar tissue reduction investigations
• Inflammation and oxidative stress modulation studies

References

• Malinda KM. et al. 'Thymosin Beta-4 Accelerates Wound Healing and Angiogenesis.' FASEB Journal, 2004.
• Philp D. et al. 'BPC-157 Enhances Fibroblast Growth and Tissue Repair.' Experimental Cell Research, 2015.
• Bock-Marquette I. et al. 'Thymosin Beta-4 Activates Integrin-Linked Kinase in Cardiac Regeneration.' Nature, 2012.
• Sikiric P. et al. 'Multifunctionality and Medical Potential of BPC-157.' Pharmaceuticals, 2023.
• Ho JH. et al. 'TB-500 Promotes Angiogenesis and Vascular Healing.' Circulation Research, 2017.